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Between Community and Hospital: Healthcare-Associated
Gram-Negative Bacteremia among Hospitalized Patients
Jonas Marschall, MD; Victoria J. Fraser, MD; Joshua Doherty, BS; David K. Warren, MD, MPH

objective. Healthcare-associated, community-acquired bacteremia is a subcategory of community-acquired bacteremia distinguished
by recent exposure of the patient to the healthcare system before hospital admission. Our objective was to apply this category to a prospective
cohort of hospitalized patients with gram-negative bacteremia to determine differences in the epidemiological characteristics, treatment,
and outcome of community-acquired bacteremia; healthcare-associated, community-acquired bacteremia; and hospital-acquired bacteremia.
design.

A 6-month prospective cohort study.

setting.

A 1,250-bed tertiary care hospital.

patients.

Adults hospitalized with gram-negative bacteremia.

results. Among 250 patients, 160 (64.0%) had bacteremia within 48 hours after admission; 132 (82.5%) of these were considered to
have healthcare-associated, community-acquired bacteremia, according to previously published criteria. For patients with healthcare-associated, community-acquired bacteremia, compared with patients with community-acquired bacteremia, malignancies (59 [44.7%] of 132
patients vs 3 [10.7%] of 28 patients; P p .001 ), open wounds at admission (42 [31.8%] vs 3 [10.7%]; P p .02 ), and intravascular catheter–
related infections (26 [19.7%] vs 0; P p .009 ) were more frequent and Escherichia coli as a causative agent was less frequent (16 [57.1%]
vs 33 [25.0%]; P p .001). There was no difference between these 2 groups in inadequate empirical antibiotic treatment (36 [27.3%] vs 6
[21.4%]; P p .5) and hospital mortality (18 [13.6%] vs 2 [[7.1%]; P p .5 ). Compared with 90 patients with hospital-acquired bacteremia,
patients with healthcare-associated, community-acquired bacteremia had a higher Charlson score (odds ratio [OR], 1.31 [95% confidence
interval (CI), 1.14–1.49]) but were less likely to have lymphoma (OR, 0.07 [95% CI, 0.01–0.51]), neutropenia (OR, 0.21 [95% CI, 0.07–
0.61]), a removable foreign body (OR, 0.08 [95% CI, 0.03–0.20]), or Klebsiella pneumoniae infection (OR, 0.26 [95% CI, 0.11–0.62]).
conclusions. Many cases of gram-negative bacteremia that occurred in hospitalized patients were healthcare associated. The patients
differed in some aspects from patients with community-acquired bacteremia and from those with hospital-acquired bacteremia, but not
in mortality.
Infect Control Hosp Epidemiol 2009; 30:1050-1056

The distinction between community- and hospital-acquired
infections among hospitalized patients is becoming increasingly blurred. Shorter hospital stays, increased outpatient
delivery of care, and a rising number of immunocompromised patients in the community account for some of
these changes.1,2 In many cases, the definition of community
acquisition does not reflect the increasing number of patients
who were exposed to the healthcare system before being admitted to the hospital. Although the difference between community- and hospital-acquired bacteremia has been studied
previously,3 the Centers for Disease Control and Prevention
definitions of nosocomial infections do not account for
healthcare-associated, community-acquired bacteremia (referred to hereafter as healthcare-associated bacteremia),4 and
they maintain the dichotomous concept of community versus

hospital acquisition. This has led to calls for a revised classification of bloodstream infections.5
In 2002, Friedman and colleagues proposed a new classification of community-acquired bloodstream infections and
established the use of the term healthcare-associated bloodstream infection. Applying a set of 4 criteria, they found many
similarities between patients with healthcare-associated infection and those with hospital-acquired infection, in terms
of comorbid conditions, sources of infection, presence of microbial pathogens, and susceptibility patterns.6 They argued
that empirical antibiotic treatment should be tailored according to this classification. Since then, few published articles
have scrutinized the new classification.7-10 Shorr et al used a
large US database to test the new classification retrospectively
in bacterial and fungal bloodstream infections,8 whereas Les-
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ens et al and Liao et al restricted their studies to healthcareassociated Staphylococcus aureus bacteremia.7,10 More recently,
other terms have been proposed to reflect the circumstances
of the acquisition of infection, such as community-acquired
healthcare-associated infection11 or community-onset healthcare-associated infection.12
Our objective was to apply the definition by Friedman and
colleagues of “healthcare association” to a prospective cohort
of hospitalized patients with gram-negative bacteremia, to
determine differences in the epidemiological characteristics,
treatment, and outcome of community-acquired bacteremia, healthcare-associated bacteremia, and hospital-acquired
bacteremia.

the adequacy of antibiotic therapy, microbiological information was entered sequentially as time blood sample was
obtained, time of notification of positive culture and Gram
stain results, time of identification of microorganism, and
time of notification of antibiotic susceptibilities. Start and
stop dates and times for the use of each antibiotic were entered sequentially.
Charlson comorbidity13 and McCabe severity of illness14
scores at admission were determined. The key clinical outcomes measured included the development of sepsis and hypotension, the subsequent transfer to the intensive care unit,
length of hospital stay after detection of positive blood culture results, and in-hospital mortality.

methods

Definitions

Setting
Barnes-Jewish Hospital, a 1,250-bed teaching hospital, is the
largest hospital in Missouri and has a referral base that includes the St Louis metropolitan area, eastern Missouri, and
western Illinois. It houses all medical specialties, including a
bone marrow transplantation unit. It is affiliated with Washington University School of Medicine.
Study Design
We performed a 6-month, prospective cohort study of patients with gram-negative bacteremia from August 1, 2006,
through January 31, 2007. We received daily electronic notification of all patients with blood cultures positive for any
organism on a list of specified gram-negative bacilli. The
automated query was run on a daily basis through the BarnesJewish Hospital Medical Informatics database, and results
were sent daily to 1 of the investigators (J.M.).
Inclusion and Exclusion Criteria
All adult patients admitted to acute care wards who presented
with or developed gram-negative bacteremia were included.
Patients were considered to have gram-negative bacteremia
if they had least 1 positive culture result; if patients had more
than 1 bacteremia episode, only the first episode was used
for this analysis. Polymicrobial infections were also included.
Patients who were bacteremic as outpatients (in clinics or in
the emergency department) and who were sent home before
a blood culture returned positive results were excluded because we could not determine with certainty the treatment
that these patients received.
Data Collection
Paper and electronic medical records were reviewed for demographic information, medical history, home medications,
vital signs, microbiological information, diagnostic and therapeutic procedures, and antimicrobial medication. All of these
sources were reviewed daily during the hospital stay. Special
attention was given to 2 areas of information: To determine

Sepsis and sepsis-induced hypotension were defined according to established criteria.15 Inadequate empirical antibiotic
treatment was defined as either no antibiotic administered or
no antibiotic administered to which all bacteria were susceptible within 24 hours after blood sample was obtained.16
Patients received a diagnosis of community-acquired,
gram-negative bacteremia if their first positive blood culture
results were obtained from blood samples drawn within 48
hours after hospital admission.3 Cases of community-acquired bacteremia were further classified as being healthcare
associated if 1 or more of the following criteria were present:
outpatient treatment, hemodialysis, or intravenous chemotherapy during the past 30 days; hospitalization for at least
2 days during the past 90 days; home intravenous therapy or
wound care during the past 30 days; or residence in a longterm care facility.6
Data Analysis and Statistical Methods
Data entry was performed with Microsoft Access and Excel
(Microsoft). Data were analyzed with SPSS, version 14 (SPSS).
Univariate comparisons among categorical variables were
performed by use of the x2 test or the Fisher exact test as
appropriate. Comparisons among continuous independent
variables were performed by use of the Student t test or the
Mann-Whitney U test as appropriate. Variables found to have
a P value of less than .1 on univariate testing were considered
for entry into a forward, stepwise multivariate logistic regression model. Multivariate analysis was applied to the comparison of healthcare-associated bacteremia and hospitalacquired bacteremia, but because of the small numbers, a
multivariate analysis could not be applied to the comparison
of healthcare-associated bacteremia and community-acquired
bacteremia (ie, bacteremia in patients without any known
healthcare exposure). A 2-sided P value of less than .05 was
considered to indicate a statistically significant difference. The
study was approved by the Washington University Human
Research Protection Office.
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figure 1. Differentiation of hospitalized patients with gramnegative bacteremia, according to method of acquisition.

results

[52.3%] vs 8 [28.6%]; P p .02). Compared with patients with
community-acquired bacteremia, for patients with healthcare-associated bacteremia, the urinary tract was less frequently the source of infection (38 [28.8%] vs 16 [57.1%];
P p .004), intravascular catheters were a more common
source of infection (26 [19.7%] vs 0; P p .009), and Escherichia coli (monomicrobial bacteremia) was less frequently
involved (33 [25.0%] vs 16 [57.1%]; P p .001).
There was no significant difference in the administration of
inadequate empirical antibiotic treatment (36 [27.3%] healthcare-associated cases vs 6 [21.4%] community-acquired cases;
P p .5), in transfer to the intensive care unit (46 [34.8%] vs
5 [17.9%]; P p .08), in length of hospital stay after the positive
blood culture sample was obtained (median, 5.5 [range, 0–
89.3] vs 4.2 [0–34.6] days; P p .09), or in in-hospital mortality
(18 [13.6%] vs 2 [7.1%]; P p .5) (Table 2).

Frequency of Healthcare-Associated Infection
among Hospitalized Patients
with Gram-Negative Bacteremia

Comparison of Healthcare-Associated Bacteremia
and Hospital-Acquired Bacteremia

We included 250 hospitalized patients with gram-negative bacteremia in our study (Figure). One hundred sixty
(64.0%) of them had community-acquired bacteremia, and
90 (36.0%) had hospital-acquired bacteremia. Overall, 207
patients (82.8%) in the cohort had prior exposure to the
healthcare system.
Among the subset of 160 patients with bacteremia within
48 hours after admission, 132 (82.5%) had healthcare-associated bacteremia, and 28 (17.5%) had community-acquired
bacteremia. Of the 90 patients with hospital-acquired bacteremia, 75 (83.3%) had prior exposure to the healthcare system.
For the 132 patients with healthcare-associated bacteremia,
we examined the 4 criteria that define healthcare association
(Table 1). The criterion most frequently present was outpatient treatment, hemodialysis, or intravenous chemotherapy
(ie, 102 [77.3%] of 132 patients). Forty patients (30.3%) received a diagnosis of healthcare-associated infection on the
basis of 1 criterion, 67 patients (50.8%) on the basis of 2
criteria, 19 patients (14.4%) on the basis of 3 criteria, and 6
patients (4.5%) on the basis of all 4 criteria.

Compared with patients with hospital-acquired bacteremia,
patients with healthcare-associated bacteremia (Table 3) had
a lower severity of illness (mean McCabe score, 1.54 vs 1.76;
P p .04). Lymphoma was less frequent among the 132 patients with healthcare-associated bacteremia than it was
among the 90 patients with hospital-acquired bacteremia (2
[1.5%] vs 13 [14.4%]; P ! .001), as was leukemia (8 [6.1%]
vs 19 [21.1%]; P p .001), neutropenia prior to the bacteremia
(9 [6.8%] vs 27 [30.0%]; P ! .001), mucositis (6 [4.5%] vs
15 [16.7%]; P p .002), and the presence of a removable foreign body (69 [52.3%] vs 81 [90.0%]; P ! .001). Conversely,
metastatic solid tumors were more frequent among patients
with healthcare-associated bacteremia than they were among
patients with hospital-acquired bacteremia (27 [20.5%] vs 4
[4.4%]; P p .001), as was dementia (14 [10.6%] vs 1 [1.1%];
P p .006).
Compared with patients with hospital-acquired bacteremia,
for patients with healthcare-associated bacteremia, the source
of infection was more often the urinary tract (38 [28.8%] vs
13 [14.4%]; P p .01) and remained less frequently unknown
(27 [20.5%] vs 32 [35.6%]; P p .01). E. coli was more com-

Comparison of Healthcare-Associated Bacteremia
and Community-Acquired Bacteremia
Compared with patients with community-acquired bacteremia (Table 2), patients with healthcare-associated bacteremia
were older (mean Ⳳ standard deviation, 57.9 Ⳳ 15.8 years
vs 54.5 Ⳳ 20.4 years; P p .046), had a higher Charlson score
(median [range], 4 [0–16] vs 1 [0–15]; P p .005), and were
more severely ill (mean McCabe score, 1.54 vs 1.25; P p
.02). Malignant tumors were more frequent among the 132
patients with healthcare-associated bacteremia than they were
among the 28 patients with community-acquired bacteremia
(59 [44.7%] vs 3 [10.7%]; P p .001), as were skin wounds
at admission (42 [31.8%] vs 3 [10.7%]; P p .02) or the presence of a removable foreign body at the time of infection (69

table 1. Frequency of the 4 Criteria That Define Healthcare Association among 132 Patients with Healthcare-Associated, Community-Acquired Bacteremia
Criterion
Outpatient treatment, hemodialysis, intravenous chemotherapy in the past 30 days
Hospitalization for 11 day in the past 90 days
Intravenous therapy or wound care at home
in the past 30 days
Residence in long-term care facility

No. (%)
of patientsa
102 (77.3)
95 (72.0)
32 (24.2)
26 (19.7)

a
More than 1 criterion can be present in a single patient; therefore,
the total exceeds 132.

table 2. Comparison of 160 Hospitalized Patients with Community-Acquired Gram-Negative
Bacteremia

Variable
Age, years, mean Ⳳ SD
Male sex
Body mass index, median (range)
Charlson score
Mean
Median (range)
McCabe score
Mean
Median (range)
Comorbidities
Congestive heart failure
Chronic pulmonary disease
Malignant tumor
Lymphoma
Leukemia
Metastatic solid tumor
Diabetes mellitus
Cerebrovascular disease
Dementia
Hemiplegia
Moderate or severe liver disease
Neutropenia
Renal insufficiencya
Hyperglycemiab
Mucositis
Skin wound at admission
Skin incision at admission
Removable foreign body presentc
Source of infection
Urinary tract
Intravascular catheter
Gastrointestinal or hepatobiliary system
Unknown
Causative microorganism
Escherichia coli
Klebsiella pneumoniae
Pseudomonas aeruginosa
Multidrug-resistant organismd
Outcome measures
Inadequate empirical antibiotic
treatment
Sepsis
Sepsis-induced hypotension
Transfer to intensive care unit
Postbacteremia length of hospital stay,
median (range), days
In-hospital death
note.
a
b
c
d

Patients with
healthcare-associated,
community-acquired
bacteremia
(n p 132)

Patients with
community-acquired
bacteremia
(n p 28)

P

57.9 Ⳳ 15.8
69 (52.3)
26.4 (13.3–66.4)

54.5 Ⳳ 20.4
9 (32.1)
28.9 (16.8–70.4)

.046
.05
.2

4.8
4 (0–16)

3.2
1 (0–15)

.005

1.54
1 (1–3)

1.25
1 (1–3)

.02

19
25
59
2
8
27
49
19
14
8
8
9
42
22
6
42
16
69

(14.4)
(18.9)
(44.7)
(1.5)
(6.1)
(20.5)
(37.1)
(14.4)
(10.6)
(6.1)
(6.1)
(6.8)
(31.8)
(16.7)
(4.5)
(31.8)
(12.1)
(52.3)

2 (7.1)
3 (10.7)
3 (10.7)
0
0
3 (10.7)
13 (46.4)
2 (7.1)
1 (3.6)
0
1 (3.6)
0
7 (25.0)
7 (25.0)
0
3 (10.7)
0
8 (28.6)

.5
.4
.001
1.99
.4
.2
.4
.5
.5
.4
1.99
.4
.5
.3
.6
.02
.08
.02

38
26
22
27

(28.8)
(19.7)
(16.7)
(20.5)

16 (57.1)
0
4 (14.3)
6 (21.4)

.004
.009
1.99
.9

33
20
9
7

(25.0)
(15.2)
(6.8)
(5.3)

16 (57.1)
2 (7.1)
0
0

.001
.3
.4
.6

36
118
62
46

(27.3)
(89.4)
(47.0)
(34.8)

6
25
8
5

5.5 (0–89.3)
18 (13.6)

(21.4)
(89.3)
(28.6)
(17.9)

4.2 (0–34.6)
2 (7.1)

Data are no. (%) of patients unless otherwise indicated. SD, standard deviation.
Creatinine level, 11.5 mg/dL.
Glucose level, 1200 mg/dL.
At the time when the blood sample was obtained for the first culture that returned positive results.
Resistance to cephalosporins, aminoglycosides, and fluoroquinolones.17

.5
1.99

.8
.08
.09
.5

table 3. Comparison of 222 Hospitalized Patients with Gram-Negative Bacteremia That Is Associated
with Exposure to the Healthcare System (Including Multivariate Analysis)

Variable
Age, years, mean Ⳳ SD
Male sex
Body mass index, median (range)
Charlson score
Mean
Median (range)
McCabe score
Mean
Median (range)
Comorbidities
Congestive heart failure
Chronic pulmonary disease
Malignant tumor
Lymphoma
Leukemia
Metastatic solid tumor
Diabetes mellitus
Cerebrovascular disease
Dementia
Hemiplegia
Moderate or severe liver disease
Neutropenia
Renal insufficiencya
Hyperglycemiab
Mucositis
Skin wound at admission
Skin incision at admission
Removable foreign body presentc
Sources of infection
Urinary tract
Intravascular catheter
Gastrointestinal or hepatobiliary system
Unknown
Causative microorganism
Escherichia coli
Klebsiella pneumoniae
Pseudomonas aeruginosa
Multidrug-resistant organismd
Outcome measures
Inadequate empirical antibiotic treatment
Sepsis
Sepsis-induced hypotension
Transfer to intensive care unit
Postbacteremia length of hospital stay,
median (range), days
In-hospital death

Patients with
healthcare-associated,
community-acquired
bacteremia
(n p 132)

Patients with
hospital-acquired
bacteremia
(n p 90)

P

57.9 Ⳳ 15.8
69 (52.3)
26.4 (13.3–66.4)

54.9 Ⳳ 15.1
48 (53.3)
26.2 (14.6–59.9)

.2
.9
1.99

OR (95% CI)

1.31 (1.14–1.49)
4.8
4 (0–16)

3.7
4 (0–12)

.05

1.54
1 (1–3)

1.76
2 (1–3)

.04

19
25
59
2
8
27
49
19
14
8
8
9
42
22
6
42
16
69

(14.4)
(18.9)
(44.7)
(1.5)
(6.1)
(20.5)
(37.1)
(14.4)
(10.6)
(6.1)
(6.1)
(6.8)
(31.8)
(16.7)
(4.5)
(31.8)
(12.1)
(52.3)

9
16
50
13
19
4
25
7
1
7
2
27
19
12
15
29
7
81

(10.0)
(17.8)
(55.6)
(14.4)
(21.1)
(4.4)
(27.8)
(7.8)
(1.1)
(7.8)
(2.2)
(30.0)
(21.1)
(13.3)
(16.7)
(32.2)
(7.8)
(90.0)

.3
.8
.1
!.001
.001
.001
.1
.1
.006
.6
.2
!.001
.08
.5
.002
.9
.3
!.001

38
26
22
27

(28.8)
(19.7)
(16.7)
(20.5)

13
14
15
32

(14.4)
(15.6)
(16.7)
(35.6)

.01
.4
1.99
.01

33
20
9
7

(25.0)
(15.2)
(6.8)
(5.3)

10
23
10
5

(11.1)
(25.6)
(11.1)
(5.6)

.01
.05
.3
1.99

36
118
62
46

(27.3)
(89.4)
(47.0)
(34.8)

37
88
35
19

(41.1)
(97.8)
(38.9)
(21.1)

.03
.02
.2
.03

8.0 (0–105.6)
15 (16.7)

.002
.5

5.5 (0–89.3)
18 (13.6)

0.07 (0.01–0.51)

0.21 (0.07–0.61)

0.08 (0.03–0.20)

0.26 (0.11–0.62)

note. Data are no. (%) unless otherwise indicated. CI, confidence interval; OR, odds ratio; SD, standard deviation.
Variables considered for entry in a forward stepwise multivariate logistic regression model included McCabe severity of
illness score at admission, Charlson comorbidity score at admission, leukemia, lymphoma, any malignant disease, metastatic solid tumor, neutropenia prior to bacteremia, diabetes mellitus, cerebrovascular disease, source in urinary tract,
unknown source of bacteremia, monomicrobial infection with E. coli, monomicrobial infection with K. pneumoniae,
serum creatinine level 11.5 mg/dL at admission, mucositis, and removable foreign body present. The ⫺2 log likelihood
value for the final model was 213.745, and the Hosmer-Lemeshow goodness-of-fit x2 test value was 12.193 (P p .143).
a
Creatinine level, 11.5 mg/dL.
b
Glucose level, 1200 mg/dL.
c
At the time when the blood sample was obtained for the first culture that returned positive results.
d
Resistance to cephalosporins, aminoglycosides, and fluoroquinolones.17

healthcare-associated gram-negative bacteremia

monly the causative pathogen in healthcare-associated infections (33 [25.0%] vs 10 [11.1%]; P p .01).
The administration of empirical antibiotic treatment was
less often inadequate in cases of healthcare-associated bacteremia than it was in cases of hospital-acquired bacteremia
(36 [27.3%] vs 37 [41.1%]; P p .03). Sepsis was less frequent
in cases of healthcare-associated bacteremia than it was in
cases of hospital-acquired bacteremia (118 [89.4%] vs 88
[97.8%]; P p .02), and the length of hospital stay after detection of bacteremia was shorter in the former group (median [range], 5.5 [0–89.3] vs 8.0 [0–105.6] days; P p .002).
Transfer to the intensive care unit more frequently occurred
among patients with healthcare-associated bacteremia than it
did among patients with hospital-acquired bacteremia (46
[34.8%] vs 19 [21.1%]; P p .03). However, there was no
significant difference in in-hospital mortality (18 patients
[13.6%] with healthcare-associated bacteremia vs 15 patients
[16.7%] with hospital-acquired bacteremia; P p .5).
In multivariate analysis (Table 3), a higher Charlson score
(odds ratio [OR], 1.31 [95% confidence interval {CI}, 1.14–
1.49]; P ! .001) was associated with healthcare-associated
bacteremia. Patients with healthcare-associated bacteremia
were less likely to have lymphoma (OR, 0.07 [95% CI, 0.01–
0.51]; P p .009), neutropenia (OR, 0.21 [95% CI, 0.07–0.61];
P p .004), a removable foreign body (OR, 0.08 [95% CI,
0.03–0.20]; P ! .001), or Klebsiella pneumoniae infection (OR,
0.26 [95% CI, 0.11–0.62]; P p .003) than were patients with
hospital-acquired bacteremia.

discussion
Only a few studies have examined the utility of the new
classification of community-acquired bacteremia proposed by
Friedman et al.6 Lesens et al and Liao et al performed prospective studies on S. aureus infection,7,10 and Shorr et al used
a large preexisting database to collect information retrospectively on various bloodstream infections.8
In our study, the majority of cases of bacteremia (82.5%)
that would conventionally be classified as community acquired were in fact healthcare associated. This is higher than
the 56.5%–59.5% reported elsewhere.6,8 In the subgroup of
gram-negative bacteria described by Shorr et al, the percentage of bloodstream infections that were healthcare-associated infections was lower than that seen in our study
(56.7%). Similarly, Friedman’s group reported that 50.9% of
their 159 cases of gram-negative bacteremia were healthcare
associated.18 There are several possible explanations for the
increased proportion of patients with healthcare-associated
infections in our study. As a result of the prospective design
of our study, we may have improved the ascertainment of
recent exposure to the healthcare system. Although previous
studies also included tertiary care centers, factors unique to
our setting may have played an additional role (eg, a large
population of bone marrow transplant recipients and cancer
patients). This is supported by the observation that the ma-
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jority (63.8%) of patients with healthcare-associated bacteremia in our study had outpatient treatment, hemodialysis, or
intravenous chemotherapy during the prior 30 days, compared with only 78 of 186 patients (42%) in an earlier study.6
Urinary tract infections were the most common source of
community-acquired bacteremia, and they were a less common source in healthcare-associated and hospital-acquired
bacteremia. This has been reported elsewhere.6 E. coli, probably the most important pathogen in gram-negative community-acquired infections,8 followed that trend closely in
our population, and the pattern was similar to that in the
population of the Shorr et al study. Unlike the work of Shorr
et al, however, which included only patients with bacteremia
detected during the first 5 days of hospitalization—which
might have distorted the epidemiological characteristics of
nosocomial pathogens—our data account for the entire hospital stay.
Patients with community-acquired bacteremia were less
likely to have malignancies or to have intravascular catheters
as a source of bacteremia than those with healthcare-associated bacteremia. Patients with hospital-acquired bacteremia
were more likely to have neutropenia or lymphoma than were
patients with healthcare-associated bacteremia. In summary,
several characteristics distinguish community-acquired bacteremia from healthcare-associated bacteremia and hospitalacquired bacteremia. Our findings therefore justify the reclassification by Friedman et al.6,10
Whether the adequacy of empirical antibiotic treatment is
an important prognostic factor in bloodstream infections is
unclear: some studies show worse outcomes,19,20 whereas others fail to demonstrate a detrimental effect of inadequate
treatment.16,18 We did not find a difference in the administration of inadequate treatment between healthcare-associated bacteremia and community-acquired bacteremia. Patients with hospital-acquired infections, however, were more
likely to receive inadequate treatment, which has been reported elsewhere.16,19
We did not find a difference in mortality rates among the
3 groups, however. This is different from the results of previous studies, which reported an increased risk of inadequate
treatment for healthcare-associated bacteremia18 and significantly higher mortality from healthcare-associated bacteremia
than from community-acquired bacteremia.6,8 Shorr and colleagues hypothesized that poor outcome in healthcare-associated infections might be largely due to the S. aureus subset,
but they did not collect data on adequacy of treatment. Other
authors could not detect differences in mortality attributable
to S. aureus bacteremia among the 3 groups of patients.7,10
Because Shorr et al did not display separate mortality rates
for infections caused by gram-negative organisms, there are
no data available for comparison of our findings.
There are a few limitations to our study. First, our study
was restricted in terms of the group of microorganisms and
in terms of patient selection, by excluding patients not sufficiently ill to be admitted to the hospital. In addition, the
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study was performed in a tertiary care center with a large
oncology department and distinct empirical prescribing patterns, which might reduce the generalizability of our findings.
Our study demonstrates that there are differences, as well
as overlapping areas, in the epidemiological characteristics of
community-acquired bacteremia, healthcare-associated bacteremia, and hospital-acquired bacteremia. The category of
healthcare-associated bacteremia seems to represent a transitional state between community- and hospital-acquired bacteremia. The original intention of distinguishing healthcareassociated bacteremia from community-acquired bacteremia
was to improve empirical treatment of patients at hospital
admission. While our study noted differences in the microbiological characteristics of gram-negative pathogens between
community-acquired bacteremia and healthcare-associated
bacteremia, there was no difference in adequacy of empirical
treatment or subsequent outcomes between these 2 types of
bacteremia. Although this classification is useful to elicit epidemiological nuances, it remains to be seen whether larger
prospective studies will show that the reclassification has an
effect on clinical outcomes.
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